Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

INTERVIEW ALERT!


Capitalizing on Brazil’s Growing Demand for Fertilizer

  • Direct Application Natural Fertilizer (DANF) product is in demand in the region
  • Flagship asset, the Bomfim Project, is 100% owned and located in one of the world’s fastest growing agrarian regions
  • Bomfim Processing Plant operating at full capacity
  • On track to produce at least ~100,000 tonnes of DANF in 2015
  • Sales contracts in place for 2015 planting season: 81,100 tonnes for ~C$8.5 million

Hub On AGORACOM / Watch Interview Now!

Message: Afrezza sales could be higher than Exubera, says Summer Street

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5496
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Afrezza sales could be higher than Exubera, says Summer Street

posted on Jul 16, 13 09:52AM

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

New Message

Please login to post a reply

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now
Watch
Today's Show
in 00:00:000

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders